Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells

Archives of Virology

Volumn 159, Issue 12, 2014, Pages 3321-3328

  Ríos Ibarra, Clara Patricia ^a   Lozano Sepulveda, Sonia ^a   Muñoz Espinosa, Linda ^a   Rincón Sánchez, Ana Rosa ^b   Cordova Fletes, Carlos ^a   Rivas Estilla, Ana María G ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVIRUS AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; ASPIRIN; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84922393228     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-014-2201-5     Document Type: Article

References (33)

1. Lok A, Seeff L, Morgan T et al (2009) Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 136(1):138–148
2. Bartenschlager R, Frese M, Pietschmann T (2004) Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63(1):71–180
3. Appel N, Schaller T, Penin F et al (2006) From structure to function: new insights into hepatitis C virus RNA replication. J Biol Chem 281(15):9833–9836
4. Kagawa T, Keeffe E, Yu M et al (2010) Pegylated interferon and ribavirin treatment for hepatitis C virus infection. Hepat Res Treat 2010:275274
5. Hoofnagle J, Seeff L (2006) Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 355(23):2444–2451
6. Modi A, Hoofnagle J (2007) New therapies for hepatitis C. Hepatology 46(3):615–617
7. Garcia-Mediavilla M, Sanchez-Campos S, Gonzalez-Perez P et al (2005) Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J Hepatol 43(4):606–613
8. Majano P, Garcia-Monzon C (2003) Does nitric oxide play a pathogenic role in hepatitis C virus infection? Cell Death Differ 10(Suppl 1):S13–S15
9. Vine C, Cole J (2011) Nitrosative stress in Escherichia coli: reduction of nitric oxide. Biochem Soc Trans 39(1):213–215
10. Mello E, Ribeiro S, Carvalho A et al (2011) Antifungal activity of PvD1 defensin involves plasma membrane permeabilization, inhibition of medium acidification, and induction of ROS in fungi cells. Curr Microbiol 62(4):1209–1217
11. Machida K, Cheng K, Sung V et al (2004) Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78(16):8835–8843
12. Pautz A, Art J, Hahn S et al (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23(2):75–93
13. Garcia-Monzon C, Majano P, Zubia I et al (2000) Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 32(2):331–338
14. Mihm S, Fayyazi A, Ramadori G (1997) Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology 26(2):451–458
15. Trujillo-Murillo K, Rincon-Sanchez A, Martinez-Rodriguez H et al (2008) Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. Hepatology 47(5):1462–1472
16. Rivas-Estilla AM, Bryan-Marrugo OL, Trujillo-Murillo K et al (2012) Cu/Zn superoxide dismutase (SOD1) induction is implicated in the antioxidative and antiviral activity of acetylsalicylic acid in HCV-expressing cells. Am J Physiol Gastrointest Liver Physiol 302(11):G1264–G1273
17. Rivas-Estilla A, Svitkin Y, Lopez-Lastra M et al (2002) PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone. J Virol 76(21):10637–10653
18. Trujillo-Murillo K, Alvarez-Martinez O et al (2007) Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity. J Viral Hepat 14(9):608–617
19. Cieslik K, Zhu Y, Wu K et al (2002) Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway. J Biol Chem 277(51):49304–49310
20. Akaike T, Maeda H (2000) Nitric oxide and virus infection. Immunology 101(1):300–308
21. Zhuang J, Lin C, Lin D et al (1998) Mutagenesis associated with nitric oxide production in macrophages. Proc Natl Acad Sci USA 95(14):8286–8291
22. Gilroy D (2005) New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins. Mem Inst Oswaldo Cruz 100(Suppl 1):49–54
23. Zaragoza C, Ocampo C et al (1997) Nitric oxide inhibition of coxsackievirus replication in vitro. J Clin Invest 100(7):1760–1767
24. Zaragoza C, Ocampo C, Saura M et al (1998) The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci USA 95(5):2469–2474
25. Mannick J, Asano K et al (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79(7):1137–1146
26. Croen K (1993) Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91(6):2446–2452
27. Akaike T, Maeda H (2000) Nitric oxide and virus infection. Immunology 101(3):300–308
28. Taylor B, de Vera M, Ganster R et al (1998) Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273(24):15148–15156
29. Wu K (2003) Control of COX-2 and iNOS gene expressions by aspirin and salicylate. Thromb Res 110(5–6):273–276
30. Ganster R, Taylor B, Shao L et al (2001) Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA 98(15):8638–8643
31. de Lucas S, Bartolome J, Amaro M et al (2003) Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation. Antiviral Res 60(2):117–124
32. Frese M, Schwarzle V, Barth K et al (2002) Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35(3):694–703
33. Kato N, Yoshida H, Ono-Nita S et al (2000) Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32(2):169–173